Editorial overview. The chemistry of drug design and lead optimization.

Desai M , Greenlee Wj
Current Opinion in Drug Discovery & Development 2 ( 4) 264

1999
The chemistry of drug design and lead optimization. Editorial overview.

Desai Mc , Greenlee Wj
Current Opinion in Drug Discovery & Development 1 ( 1) 352

1998
Acute hypotensive responses to peptide inhibitors of renin in conscious monkeys: an effect on blood pressure independent of plasma renin inhibition.

Linda W. Schaffer , Terry W. Schorn , Raymond J. Winquist , John F. Strouse
Journal of Hypertension 8 ( 3) 251 -259

12
1990
An efficient synthesis of γ-amino-β-ketoalkylphosphonates from α-amino acids

P.K Chakravarty , P Combs , A Roth , W.J Greenlee
Tetrahedron Letters 28 ( 6) 611 -612

19
1987
In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996

S KIVLIGHN , G ZINGARO , R GABEL , T BROTEN
American Journal of Hypertension 8 ( 1) 58 -66

17
1995
3
1994
USE OF ENZYME CRYSTAL-STRUCTURES AND COMPUTER-GRAPHICS FOR INHIBITOR DESIGN THERMOLYSIN AS A MODEL FOR ANGIOTENSIN CONVERTING ENZYME

D HANGAUER , D ONDEYKA , H BULL , N THORNBERRY
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 190 ( SEP) 50 -MEI

1985
Backup programs in drug discovery.

Manoj Desai , William J Greenlee
Current Opinion in Drug Discovery & Development 9 ( 4) 412

1
2006
The role of medicinal chemists in drug discovery.

Manoj C Desai , William J Greenlee
Current Opinion in Drug Discovery & Development 8 ( 4) 419

2005
Editorial overview: Transporter proteins in drug disposition and uptake.

Manoj C Desai , William J Greenlee
Current Opinion in Drug Discovery & Development 7 ( 4) 395 -395

2004
Muscarinic M2 antagonists: anthranilamide derivatives with exceptional selectivity and in vivo activity.

John W Clader , William Billard , Herbert Binch , Lian-Yong Chen
Bioorganic & Medicinal Chemistry 12 ( 2) 319 -326

14
2004
Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors

Yuguang Wang , Samuel Chackalamannil , Zhiyong Hu , Craig D Boyle
Bioorganic & Medicinal Chemistry Letters 12 ( 21) 3149 -3152

28
2002
Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonist

David L Williams , Kathryn L Murphy , Nancy A Nolan , Julie A O'Brien
Life Sciences 58 ( 14) 1149 -1157

9
1996
SAR development of polycyclic guanine derivatives targeted to the discovery of a selective PDE5 inhibitor for treatment of erectile dysfunction

Dmitri A Pissarnitski , Theodros Asberom , Craig D Boyle , Samuel Chackalamannil
Bioorganic & Medicinal Chemistry Letters 14 ( 5) 1291 -1294

19
2004
(3-Amino-2-oxoalkyl) phosphonic acids and their analogs as novel inhibitors of D-alanine: D-alanine ligase

Prasun K Chakravarty , William J Greenlee , William H Parsons , Arthur A Patchett
Journal of medicinal chemistry 32 ( 8) 1886 -1890

116
1989
Identification of a selective SCoR2 inhibitor that protects against acute kidney injury

Hua-Lin Zhou , Alfred Hausladen , Puneet Anand , Malligarjunan Rajavel
Journal of medicinal chemistry 66 ( 8) 5657 -5668

2023
Design and synthesis of novel b-secretase (BACE) inhibitors

Robert D Mazzola Jr , Suresh Babu , John Caldwell , Xia Chen
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 240

2010
Modeling novel planar BACE1 inhibitors: Trying to hit a moving target

Johannes Voigt , John Caldwell , Samuel Chackalamannil , Xia Che
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 238

2009